Department of Medical, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China.
Department of Ophthalmology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China.
Int Immunopharmacol. 2020 Jun;83:106395. doi: 10.1016/j.intimp.2020.106395. Epub 2020 Mar 18.
Glaucoma is a kind of blind-causing disease with structural damages of optic nerve and defection of visual field. It is believed that the death of retinal ganglion cell (RGC) is a consequential event of over-reactive immune orchestral cells such as microglia. Previous evidences in animal and clinical studies show the innate immunity plays a pivotal role in neuro-inflammation of glaucoma. Toll-like receptor 4 (TLR4) is expressed on microglia and mediates many neuroinflammatory diseases. We aimed to explore the impacts of high intraocular pressure (IOP) on rat microglia in retina and the regulation of TLR4/NF-κB signaling pathway in scratched microglia cells. In our study, we successfully established chronic high IOP rat model by episcleral vein cauterization (EVC) which behaved like the chronic glaucoma. Besides, we set up an in vitro scratch-induced injury model in rat microglia cells. We found the level of activated microglia cells were significantly increased in the retina of chronic high IOP groups. Moreover, the inhibition of TLR4/NF-κB signaling pathway suppressed the expression of TLR4 protein and mRNA levels of P50, IL-6 and TNF-α. Our original study provided a theoretical basis on targeting TLR4/NF-κB to suppress pro-inflammatory factors releasing in activated microglia and it might be a good treatment target to prevent glaucoma from progressing.
青光眼是一种致盲性疾病,其特征为视神经结构损伤和视野缺损。据认为,视网膜神经节细胞(RGC)的死亡是小胶质细胞等过度反应性免疫细胞的必然结果。动物和临床研究的先前证据表明,固有免疫在青光眼的神经炎症中起关键作用。Toll 样受体 4(TLR4)在小胶质细胞上表达,并介导许多神经炎症性疾病。我们旨在探讨高眼压(IOP)对视网膜中小胶质细胞的影响,以及 TLR4/NF-κB 信号通路在划痕小胶质细胞中的调节作用。在我们的研究中,我们通过巩膜静脉烧灼术(EVC)成功建立了慢性高眼压大鼠模型,该模型表现为慢性青光眼。此外,我们建立了大鼠小胶质细胞体外划痕损伤模型。我们发现慢性高眼压组视网膜中活化小胶质细胞的水平明显升高。此外,TLR4/NF-κB 信号通路的抑制抑制了 TLR4 蛋白和 P50、IL-6 和 TNF-α 的 mRNA 水平的表达。我们的原始研究为靶向 TLR4/NF-κB 抑制活化小胶质细胞中促炎因子释放提供了理论依据,这可能是预防青光眼进展的一个很好的治疗靶点。